ハンチントン病治療薬市場2020：地域の見通し（アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカ）別のサイズ、業界分析レポート、成長の可能性、価格動向、競争力のある市場シェア、市場統計と予測2020-2025 (アップデート版あり)

このレポートには、最新の市場図、統計、データが含まれています

ライセンスを選択

概要
目次

ハンチントン病は、中枢神経系（CNS）の神経細胞の変性を引き起こす遺伝性疾患です。この病気は人間の機能的能力に幅広い影響を及ぼし、通常は運動障害や思考障害を引き起こします。ハンチントン病のほとんどの人は、30〜40歳で徴候や症状を発症します。20歳より前に病気が始まると、その状態は若年性ハンチントン病として知られています。
まとめグローバルハンチントン病治療薬市場は、2015年から2019年までのCAGR xx％でxxx百万米ドルと評価されました。その後、2020年にはXXX百万米ドルに達し、2020年から2025年までのCAGRはxx％になります。

世界のハンチントン病治療薬市場では、このレポートは特に北アメリカ、南アメリカ、ヨーロッパとアジア太平洋、および中東とアフリカに焦点を当てています。このレポートは、アプリケーション、タイプ、地域、および製造業者に基づいて市場を分類します。

メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Auspex Pharmaceuticals
Alnylam Pharmaceuticals
Intellect Neurosciences Incorporation
H. Lundbeck
Prana Biotechnology Limited
Raptor Pharmaceuticals
Sangamo Biosciences
Teva Pharmaceutical Industries
Trophos SA
Valeant Pharmaceuticals International
Vertex Pharmaceuticals
Roche

地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）

タイプによる市場細分化：
Antidopaminergics
抗痙攣薬
抗精神病薬
抗うつ薬
アプリケーションによる市場細分化：
Hosptial
診療所
研究
この調査は、次の重要な質問に対する回答を提供します。
• 2020年から2025年の予測期間におけるハンチントン病治療薬市場の推定成長率と市場シェアおよび規模はどのくらいですか？
• 予測期間2020年から2025年のハンチントン病治療薬市場の原動力は何ですか？
• 著名なマーケットプレーヤーは誰ですか？彼らは他の競合他社に対してどのように競争力を獲得しましたか？
• 世界中のハンチントン病治療薬の業界の進歩に影響を与える市場動向は何ですか？
• 業界の進歩を制限する主な課題と脅威は何ですか？
• 市場は著名な市場プレーヤーにとってどのような機会を持っていますか？
このレポートに関する特別な要件がある場合は、お知らせください。カスタムレポートを提供できます。

注–より正確な市場予測を提供するために、COVID-19の影響を考慮して、すべてのレポートが配信前に更新されます。

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Huntingtons Disease Therapeutics Market Size Growth Rate by Type (2020-2025)
1.3.2 Antidopaminergics
1.3.3 Anticonvulsants
1.3.4 Antipsychotics
1.3.5 Antidepressants
1.4 Market Segment by Application
1.4.1 Global Huntingtons Disease Therapeutics Market Share by Application (2020-2025)
1.4.2 Hosptial
1.4.3 Clinic
1.4.4 Research
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Huntingtons Disease Therapeutics Market Size
2.1.1 Global Huntingtons Disease Therapeutics Revenue 2015-2025
2.1.2 Global Huntingtons Disease Therapeutics Sales 2015-2025
2.2 Huntingtons Disease Therapeutics Growth Rate by Regions
2.2.1 Global Huntingtons Disease Therapeutics Sales by Regions 2015-2019
2.2.2 Global Huntingtons Disease Therapeutics Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Huntingtons Disease Therapeutics Sales by Manufacturers
3.1.1 Huntingtons Disease Therapeutics Sales by Manufacturers 2015-2019
3.1.2 Huntingtons Disease Therapeutics Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Huntingtons Disease Therapeutics Revenue by Manufacturers (2015-2019)
3.2.2 Huntingtons Disease Therapeutics Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Huntingtons Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.3 Huntingtons Disease Therapeutics Price by Manufacturers
3.4 Key Manufacturers Huntingtons Disease Therapeutics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Huntingtons Disease Therapeutics Market
3.6 Key Manufacturers Huntingtons Disease Therapeutics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Antidopaminergics Sales and Revenue (2015-2019)
4.1.2 Anticonvulsants Sales and Revenue (2015-2019)
4.1.3 Antipsychotics Sales and Revenue (2015-2019)
4.1.4 Antidepressants Sales and Revenue (2015-2019)
4.2 Global Huntingtons Disease Therapeutics Sales Market Share by Type
4.3 Global Huntingtons Disease Therapeutics Revenue Market Share by Type
4.4 Huntingtons Disease Therapeutics Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Huntingtons Disease Therapeutics Sales by Application

6 United States
6.1 United States Huntingtons Disease Therapeutics Breakdown Data by Company
6.2 United States Huntingtons Disease Therapeutics Breakdown Data by Type
6.3 United States Huntingtons Disease Therapeutics Breakdown Data by Application

7 European Union
7.1 European Union Huntingtons Disease Therapeutics Breakdown Data by Company
7.2 European Union Huntingtons Disease Therapeutics Breakdown Data by Type
7.3 European Union Huntingtons Disease Therapeutics Breakdown Data by Application

8 China
8.1 China Huntingtons Disease Therapeutics Breakdown Data by Company
8.2 China Huntingtons Disease Therapeutics Breakdown Data by Type
8.3 China Huntingtons Disease Therapeutics Breakdown Data by Application

9 Rest of World
9.1 Rest of World Huntingtons Disease Therapeutics Breakdown Data by Company
9.2 Rest of World Huntingtons Disease Therapeutics Breakdown Data by Type
9.3 Rest of World Huntingtons Disease Therapeutics Breakdown Data by Application
9.4 Rest of World Huntingtons Disease Therapeutics Breakdown Data by Countries
9.4.1 Rest of World Huntingtons Disease Therapeutics Sales by Countries
9.4.2 Rest of World Huntingtons Disease Therapeutics Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Auspex Pharmaceuticals
10.1.1 Auspex Pharmaceuticals Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
10.1.4 Huntingtons Disease Therapeutics Product Introduction
10.1.5 Auspex Pharmaceuticals Recent Development
10.2 Alnylam Pharmaceuticals
10.2.1 Alnylam Pharmaceuticals Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
10.2.4 Huntingtons Disease Therapeutics Product Introduction
10.2.5 Alnylam Pharmaceuticals Recent Development
10.3 Intellect Neurosciences Incorporation
10.3.1 Intellect Neurosciences Incorporation Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
10.3.4 Huntingtons Disease Therapeutics Product Introduction
10.3.5 Intellect Neurosciences Incorporation Recent Development
10.4 H. Lundbeck
10.4.1 H. Lundbeck Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
10.4.4 Huntingtons Disease Therapeutics Product Introduction
10.4.5 H. Lundbeck Recent Development
10.5 Prana Biotechnology Limited
10.5.1 Prana Biotechnology Limited Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
10.5.4 Huntingtons Disease Therapeutics Product Introduction
10.5.5 Prana Biotechnology Limited Recent Development
10.6 Raptor Pharmaceuticals
10.6.1 Raptor Pharmaceuticals Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
10.6.4 Huntingtons Disease Therapeutics Product Introduction
10.6.5 Raptor Pharmaceuticals Recent Development
10.7 Sangamo Biosciences
10.7.1 Sangamo Biosciences Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
10.7.4 Huntingtons Disease Therapeutics Product Introduction
10.7.5 Sangamo Biosciences Recent Development
10.8 Teva Pharmaceutical Industries
10.8.1 Teva Pharmaceutical Industries Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
10.8.4 Huntingtons Disease Therapeutics Product Introduction
10.8.5 Teva Pharmaceutical Industries Recent Development
10.9 Trophos SA
10.9.1 Trophos SA Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
10.9.4 Huntingtons Disease Therapeutics Product Introduction
10.9.5 Trophos SA Recent Development
10.10 Valeant Pharmaceuticals International
10.10.1 Valeant Pharmaceuticals International Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Huntingtons Disease Therapeutics
10.10.4 Huntingtons Disease Therapeutics Product Introduction
10.10.5 Valeant Pharmaceuticals International Recent Development
10.11 Vertex Pharmaceuticals
10.12 Roche

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Huntingtons Disease Therapeutics Sales Channels
11.2.2 Huntingtons Disease Therapeutics Distributors
11.3 Huntingtons Disease Therapeutics Customers

12 Market Forecast
12.1 Global Huntingtons Disease Therapeutics Sales and Revenue Forecast 2020-2025
12.2 Global Huntingtons Disease Therapeutics Sales Forecast by Type
12.3 Global Huntingtons Disease Therapeutics Sales Forecast by Application
12.4 Huntingtons Disease Therapeutics Forecast by Regions
12.4.1 Global Huntingtons Disease Therapeutics Sales Forecast by Regions 2020-2025
12.4.2 Global Huntingtons Disease Therapeutics Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer